Seeing Is Believing
BCTX is currently covered by 1 analysts with an average price target of $-8.42. This is a potential upside of $-21.5 (-164.37%) from yesterday's end of day stock price of $13.08.
Briacell Therapeutics Corp's activity chart (see below) currently has 0 price targets and 14 ratings on display. The stock rating distribution of BCTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 22 days.
Highest price target for BCTX is $32, Lowest price target is $32, average price target is $32.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 22-Apr-2025. First documented stock forecast 14-Feb-2022.
Currently out of the existing stock ratings of BCTX, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$32
$18.92 (144.65%)
$32
5 months 13 days ago
(22-Apr-2025)
2/2 (100%)
$-21.5 (-40.19%)
22
What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?
Which analyst has the current highest performing score on BCTX (Briacell Therapeutics Corp) with a proven track record?
Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?
Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?